Carregant...
Is Initiating NOACs for Atrial Arrhythmias Safe in Adults with Congenital Heart Disease?
BACKGROUND: In recent years, non-vitamin K antagonist (VKA) oral anticoagulants (NOACs) have been increasingly prescribed to adults with congenital heart disease (CHD) and atrial arrhythmias without good evidence for either safety or efficacy. To address this gap, we initiated an ongoing prospective...
Guardat en:
| Publicat a: | Cardiovasc Drugs Ther |
|---|---|
| Autors principals: | , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Springer US
2017
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5591797/ https://ncbi.nlm.nih.gov/pubmed/28785894 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10557-017-6745-y |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|